Brand tirzepatide
Sold by GOAL.MD · Injection, vial · every brand tirzepatide record
What you actually pay
Per month
$489
| Medication · LillyDirect pricing | $394 |
|---|---|
| Required membership | $95 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| LillyDirect pricing “Get Zepbound® vials (tirzepatide) prescribed online by a US physician. LillyDirect pricing from $394/mo. Free shipping, FSA/HSA eligible.” source, read September 2, 2026 | Per month$394 | Charged today$394 |
We earn nothing from this link. GOAL.MD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- September 2, 2026 — $394
- September 3, 2026 — $394
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Membership | Required. $95 per month. “Access brand-name weight loss medications through manufacturer savings programs. GOAL.MD provides physician evaluation for $95/month.” |
| Consult fee | None. “Free consultation · FSA/HSA eligible · No auto-billing on compounded programs” |
Not yet checked: pharmacy, states and cancellation.
Recorded from goal.md. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — This is a heavily client-rendered site: most routes (pricing, terms, refund policy, dedicated FAQ, /semaglutide, /tirzepatide, /cost, /plans, /medicare-glp1-bridge) return only a generic 53-character homepage shell in this tool's output. Substantive content was only recoverable via sitemap.xml plus individual landing pages whose real content lives in the meta description (visible as page text). No terms/refund/cancellation page could be reached, so cancellation is recorded as not found even though '3-month plan' language and 'No auto-billing' appear on the semaglutide page. 'Free consultation, nationwide' falls short of an explicit 50-state claim. The $95/month 'Brand-Name GLP-1 Access' fee is a physician-evaluation membership that explicitly excludes the medication (billed separately via TrumpRx/LillyDirect) — a clean example of the membership-vs-price distinction this brief warns about.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.